The Comprehensive Cancer Center at Wake Forest Baptist Medical Center is among the elite group of cancer centers acknowledged as the nation’s leaders in the fight against cancer. The Center’s cancer experts offer the latest cancer treatments to their patients and conduct groundbreaking research in the field. The Center has just been awarded an $18 million, five-year grant by the National Cancer Institute’s Community Oncology Research Program. The Center is only one of two cancer centers to receive the designation; the Center will conduct community-based, multi-center clinical trials that focus on the entire life cycle of cancer treatment from prevention to remission.
A distinction of the program will be an emphasis on studying quality of life and functional status of individuals who have been cured of cancer. With a significant increase in cancer survivors, light is being shed on the often severe and prolonged side effects of cancer therapies. In addition, the grant will focus on minorities and underserved populations, reflected by the 22 community and minority sites that have already joined Wake Forest Baptist’s clinical trial network.
Overall, the researchers hope to uncover better pathways to prevention and treatment. “Our goal is to improve the quality of life and care experienced by patients with cancer by reducing or preventing treatment-related symptoms and toxicities and improving cancer care delivery,” said Glenn Lesser, MD, professor of hematology and oncology at Wake Forest Baptist and principal investigator of the NCORP-funded project.